Biliary Tract Carcinoma — Trials

Biliary Tract Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 238
Recruiting: 138
Ph III recruiting: 9
Growth YoY: +12.7%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (111)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00660140	Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer	completed	Phase 2	49	Washington University School of MedicineOTHER	1	Aug 13, 2013	clinicaltrials
NCT00033462	Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer	completed	Phase 2	78	National Cancer Institute (NCI)NIH	1	Jun 4, 2013	clinicaltrials